Clinical Trials Browser

Phase 2 × sugemalimab × Clear all

NCT05940532 2023-07-11

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung